1.Ruggieri, et al. Induction treatment strategy in multiple sclerosis: a review of past experiences and future perspectives. Multiple Sclerosis and Demyelinating Disorders (2018).
2.Cerqueira JJ, et al. Time matters in multiple sclerosis: can early treatment and long-term follow-up ensure everyone benefis from the latest advances in multiple sclerosis? J Neurol Neurosurg Psychiatry 2018; 89: 844–50. 3:5.
3.中华医学会神经病学分会神经免疫学组. 多发性硬化诊断与治疗中国指南(2023版)[J]. 中华神经科杂志,2024,57(01):10-23.
4.Heinz Wiendl, et al. Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper). Ther Adv Neurol Disord. 2021 Aug 18;14:17562864211039648.
5.Cecilia Rajda, et al. Treatment of relapsing multiple sclerosis in Hungary - consensus recommendation from the Hungarian neuroimmunology society. Orphanet J Rare Dis . 2023 Jul 7;18(1):183.
6.Takahiko Saida, et al. 日本におけるリアルワールドデータ〜 510例の使用経験を中心に〜. 厚生労働省 神経免疫班会議 2024.1.
7.Umakanth Vudumula, et al. Evaluating the impact of early vs delayed ofatumumab initiation and estimating the long-term outcomes of ofatumumab vs teriflunomide in relapsing multiple sclerosis patients in Spain. J Med Econ. 2023 Jan-Dec;26(1):11-18.
8.Dominik Koeditz, et al. Comparing the long-term clinical and economic impact of ofatumumab versus dimethyl fumarate and glatiramer acetate in patients with relapsing multiple sclerosis: A cost-consequence analysis from a societal perspective in Germany. Mult Scler J Exp Transl Clin . 2022 Mar 29;8(1):20552173221085741.
9.Helmut Butzkueven, et al. Employing Novel Indirect Treatment Comparison Methodologies to Differentiate the Efficacy of Ofatumumab and Other High Efficacy Therapies versus Orally Administered Disease Modifying Therapies for Relapsing Multiple Sclerosis. The 9thJoint ECTRIMS-ACTRIMS meeting. P755
10.《2020中国多发性硬化患者综合社会调查报告》
11.Sahloul O, et al. Evidence of disease activity during pregnancy and post-partum in MS patients treated with high-efficacy therapies. Mult Scler Relat Disord. 2024 May;85:105557.
12.Riley Bove,et al. Poster Presentation at the American Academy of Neurology (AAN) 2023, April 22-27, 2023.
13.Malek A, Sager R, Kuhn P, et al. Evolution of maternofetal transport of immunoglobulins during human pregnancy. Am J Reprod Immunol 1996;36:248–55.